Navigation Links
DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
Date:8/28/2007

SOMERSET, N.J., Aug. 28 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the "Company") (OTC Bulletin Board and Pink Sheets: DOVP) announced today that its common stock is now being quoted on the OTC Bulletin Board. The Company understands that its common stock is also still being quoted on the Pink Sheets.

"We are pleased that shares of our common stock are now being quoted both on the OTC Bulletin Board and the Pink Sheets," said Barbara Duncan, Chief Executive Officer of DOV. "We believe this dual quotation on the OTC Bulletin Board and the Pink Sheets provides the Company with greater visibility in the investment community and offers our shareholders, both current and future, greater liquidity."

About DOV

DOV is a biopharmaceutical company focused on the discovery, acquisition and development of novel drug candidates for central nervous system disorders. The Company's product candidates address some of the largest pharmaceutical markets in the world including depression, pain and insomnia.

Cautionary Note

Statements in this press release that are not historical facts constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. You can also identify forward-looking statements by the following words: may, will, should, expect, intend, plan, anticipate, believe, estimate, predict, potential, continue or the negative of these terms or other comparable terminology. We caution you that forward-looking statements are inherently uncertain and are simply point-in-time estimates based on a combination of facts and factors currently known by us about which we cannot be certain or even relatively confident. Actual results or events will surely differ and may differ materially from our forward-looking statements as a result of many factors, some of which we may not be able to predict or may not be within our contro
'/>"/>

SOURCE DOV Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. DeForest biodiesel plant begins production
2. Deltanoid Pharmaceuticals begins phase II osteoporosis study
3. Prodesse begins clinical trials for flu virus detection
4. Closing the income gap begins with education
5. Corporate control begins with a strong board
6. Emerging game developer begins work on prototypes
7. GE begins human trials for cancer detection agent
8. Now the real work begins
9. Esker begins automated faxing and mailing service
10. Its not exactly OPEC, but Midwest states are trading ideas on biofuels
11. Avoid Trading Tech Relationships Like Pokmon Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)... 2007, Joe Weitz left his position of 15 years as ...Lastar Inc. to form American Consumer Cables.com. ...Force veterans he partners with at American Consum...ers of technology-based connectivity solutions; on... product solutions including audio cables, Cat5E c...
(Date:10/12/2008)... Oct. 12 /- Mentice, Inc., a,leading ...ed medical,simulation systems and Education Manage...kills training and evaluation software solutions, ...r Therapeutics symposium in,Washington D.C., an OE...ceSIM(TM) as a standard option to its flagship Vas...
(Date:10/10/2008)...RNewswire-FirstCall/ -- Neurobiological,Technologi...d it will hold a,conference call on Monday, Octobe...crod) Phase 3 Trial Program for acute ischemic str...sident and chief executive,officer and Warren W. W...ay, October 13, 2008 -- Time: 1:00 p.m. (ET), 12...
(Date:10/10/2008)...he Sixth Milestone in its Ofatumumab ...nmark, October 10 /- Genmab... sixth milestone for,ofatumumab (HuMax-CD20(R)) un...Kline (GSK). A milestone payment of approximately ... triggered by the first patient,receiving treatmen...
Breaking Biology Technology: Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off 2Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 2Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 3Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2Genmab Reaches Milestone in Ofatumumab Collaboration 2
...is. - Merge Healthcare has released yet another...ormation system and a picture archiving and commun...ication. , ,Merge, a medical imaging software and ...s called Fusion RIS/PACS, to imaging centers, hosp...cialty clinics. , ,The product is designed to deli...
... - Is America rushing into the adoption of electr...hout enough concern for data security? , ,The ques... Congress, where some bills seek to provide incent...onal health records, and others that raise privacy...on of EMRs. , ,Moreover, headline-grabbing data br...
...: Last month, the information security firm Sym...Security Threat Report . This is Symantec,s attemp...for the trees, and these woods look pretty ominous...ec security response organization. , , The name o...f malicious code targets specific organizations fo...
...s. - Citing the need to deliver an independent, l...ntext of its electronic medical records, Aurora H...ormation management product developed by TeraMedi...,The installation, which will occur over the next ...s medical images and distribute them to attending ...
Other Biology Technology:Privacy, trust still the biggest barriers to electronic record sharing 2Privacy, trust still the biggest barriers to electronic record sharing 3Symantec: Cyber fraudsters look for low-hanging fruit 2Symantec: Cyber fraudsters look for low-hanging fruit 3Symantec: Cyber fraudsters look for low-hanging fruit 4Symantec: Cyber fraudsters look for low-hanging fruit 5Symantec: Cyber fraudsters look for low-hanging fruit 6Symantec: Cyber fraudsters look for low-hanging fruit 7
(Date:10/13/2008)...t-traveling migratory moths may hitch a ride on th...of Current Biology, a Cell Press publication, co...previous report also in Current Biology offered ...ophisticated internal compass, sailing on favorabl...n within a matter of days. Now, the research team ...
(Date:10/13/2008)...research may help reveal why different parts of th...tiple sclerosis (MS). According to a new study in ... to a protein produced by invading T cells dictate...comes under fire. The studyfrom researchers at the...imore and Washington University in St. Louiswill b...
(Date:10/12/2008)...ntists at Bonn and Dsseldorf Universities have dis...study, the researchers investigated over 500,000 p...iant which occurs clearly more frequently in bald ... published in the November issue of the journal N...h 2008 18:00 London time, doi: 10.1038/ng.228). In...
(Date:10/10/2008)...ital for Special Surgery researchers have found th...women who are suffering from pregnancy complicatio...rding to a study in mice. In this autoimmune syndr...pholipids, the main components of cell membranes. ...ber issue of the Journal of Clinical Investigatio...
Breaking Biology News(10 mins):Migratory moths may hitch their rides, but they're anything but drifters 2Important new hair-loss gene discovered 2Statins may prevent miscarriages 2Statins may prevent miscarriages 3Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 1Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 2Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 3Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 4If you think cancer genes are simple you dont know JAK 1350 1If you think cancer genes are simple you dont know JAK 1350 2If you think cancer genes are simple you dont know JAK 1350 3If you think cancer genes are simple you dont know JAK 1350 4If you think cancer genes are simple you dont know JAK 1350 5Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 1Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 3BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 1BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 2BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 3
...elsh streams and rivers, affecting the number and ... Cardiff University study has found. , Rivers and...es and form important links with surrounding habit...the ecological effects of climate change on these ...y at Llyn Brianne in central Wales, led by Profess...
... mice from developing a brain disease similar to m... presented at the American Academy of Neurology,s ...07. Prion diseases, which include scrapie, mad cow...nd there is no treatment or cure. , The disease s... animals contaminated with prions. The disease cau...
...ule in the body appears to control whether certain...nists used in acute heart failure or in inhalers f...itric oxide is a molecule produced by the body tha...on or dilation of blood vessels. , New experime...d Howard Hughes Medical Institute researchers have...
...Fuel companies aren,t touting that slogan. At leas...y Bruce Dale, Michigan State University professor ...ing fuels from poplar trees and corn stalks is bec... is internationally known for his 30 years of rese...ms, leaves, stalks and trunks of plants and trees ...
Other Biology News:Vaccine prevents prion disease in mice 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 3
Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C.
Designed for flow cytometric applications intended to identify
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins
RABBIT ANTI HUMAN CYTOCHROME P450 1A1/2 Immunogen: Purified human CYP1A2 expressed in E.Coli
Biology Products: